Italia markets closed

BMY Jun 2025 55.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,4100+0,0100 (+0,71%)
In data: 02:38PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,4000
Aperto1,4100
Denaro0,3900
Lettera2,8200
Prezzo d'esercizio55,00
Scadenza2025-06-20
Min-Max giorno1,4100 - 1,4100
Contratto - Min-MaxN/D
Volume25
Open Interest278
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri